Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Overcoming challenges to data quality in the ASPREE clinical trial.

Lockery JE, Collyer TA, Reid CM, Ernst ME, Gilbertson D, Hay N, Kirpach B, McNeil JJ, Nelson MR, Orchard SG, Pruksawongsin K, Shah RC, Wolfe R, Woods RL; ASPREE Investigator Group.

Trials. 2019 Dec 9;20(1):686. doi: 10.1186/s13063-019-3789-2.

2.

The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.

Maharaj AD, Holland JF, Scarborough RO, Evans SM, Ioannou LJ, Brown W, Croagh DG, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong CP, Evans P, Goldstein D, Haydon A, Hii MW, Knowles BPF, Merrett ND, Michael M, Neale RE, Philip J, Porter IWT, Smith M, Spillane J, Tagkalidis PP, Zalcberg JR.

BMJ Open. 2019 Sep 30;9(9):e031434. doi: 10.1136/bmjopen-2019-031434.

3.

What matters most to patients following percutaneous coronary interventions? A new patient-reported outcome measure developed using Rasch analysis.

Soh SE, Barker AL, Ayton DR, Ahern S, Morello R, Lefkovits J, Brennan AL, Evans S, Zalcberg JR, Reid CM, McNeil JJ.

PLoS One. 2019 Sep 5;14(9):e0222185. doi: 10.1371/journal.pone.0222185. eCollection 2019.

4.

Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study.

Davis SR, Bell RJ, Robinson PJ, Handelsman DJ, Gilbert T, Phung J, Desai R, Lockery JE, Woods RL, Wolfe RS, Reid CM, Nelson MR, Murray AM, McNeil JJ; ASPREE Investigator Group.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6291-6300. doi: 10.1210/jc.2019-00743.

PMID:
31408149
5.

Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study.

Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M; ASPREE Investigator Group.

CNS Drugs. 2019 Jul;33(7):685-694. doi: 10.1007/s40263-019-00633-3.

6.

Effects of Aspirin in the Healthy Elderly. Reply.

McNeil JJ, Woods RL, Murray AM; ASPREE Investigator Group.

N Engl J Med. 2019 May 2;380(18):1776-1777. doi: 10.1056/NEJMc1901774. No abstract available.

7.

Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States.

Mohebbi M, Agustini B, Woods RL, McNeil JJ, Nelson MR, Shah RC, Nguyen V, Storey E, Murray AM, Reid CM, Kirpach B, Wolfe R, Lockery JE, Berk M; ASPREE Investigator Group.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1208-1216. doi: 10.1002/gps.5119. Epub 2019 May 8.

PMID:
30989707
8.

Correction: Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.

Zhang L, Bao Y, Riaz M, Tiller J, Liew D, Zhuang X, Amor DJ, Huq A, Petelin L, Nelson M, James PA, Winship I, McNeil JJ, Lacaze P.

Genet Med. 2019 Sep;21(9):2162-2163. doi: 10.1038/s41436-019-0515-0.

PMID:
30944416
9.

Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study.

Lockery JE, Collyer TA, Abhayaratna WP, Fitzgerald SM, McNeil JJ, Nelson MR, Orchard SG, Reid C, Stocks NP, Trevaks RE, Woods R.

Med J Aust. 2019 Mar;210(4):168-173. doi: 10.5694/mja2.12060. Epub 2018 Dec 21.

PMID:
30835844
10.

Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.

Zhang L, Bao Y, Riaz M, Tiller J, Liew D, Zhuang X, Amor DJ, Huq A, Petelin L, Nelson M, James PA, Winship I, McNeil JJ, Lacaze P.

Genet Med. 2019 Sep;21(9):1958-1968. doi: 10.1038/s41436-019-0457-6. Epub 2019 Feb 18. Erratum in: Genet Med. 2019 Apr 4;:.

11.

Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study.

McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, Storey E, Shah RC, Wolfe RS, Tonkin AM, Newman AB, Williamson JD, Lockery JE, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Trevaks RE, Orchard SG, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Grimm RH; ASPREE Investigator Group.

J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):748. doi: 10.1093/gerona/gly278. No abstract available.

12.

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly study cohort.

Polkinghorne KR, Wolfe R, Jachno KM, Wetmore JB, Woods RL, McNeil JJ, Nelson MR, Reid CM, Murray AM; ASPREE Investigator Group.

Nephrology (Carlton). 2019 Dec;24(12):1248-1256. doi: 10.1111/nep.13565. Epub 2019 May 7.

13.

Cohort Profile: The ASPREE Longitudinal Study of Older Persons (ALSOP).

McNeil JJ, Woods RL, Ward SA, Britt CJ, Lockery JE, Beilin LJ, Owen AJ.

Int J Epidemiol. 2019 Aug 1;48(4):1048-1049h. doi: 10.1093/ije/dyy279. No abstract available.

PMID:
30624660
14.

Retention of medical records of patients with high-risk medical devices.

Cooter RD, Hopper I, McNeil JJ.

Med J Aust. 2018 Nov 19;209(10):461. No abstract available.

PMID:
30428821
15.

Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors.

Stocks NP, González-Chica DA, Woods RL, Lockery JE, Wolfe RSJ, Murray AM, Kirpach B, Shah RC, Nelson MR, Reid CM, Ernst ME, McNeil JJ; ASPREE Investigator Group.

Qual Life Res. 2019 Apr;28(4):935-946. doi: 10.1007/s11136-018-2040-z. Epub 2018 Nov 8.

PMID:
30411180
16.

The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design.

Lacaze P, Pinese M, Kaplan W, Stone A, Brion MJ, Woods RL, McNamara M, McNeil JJ, Dinger ME, Thomas DM.

Eur J Hum Genet. 2019 Feb;27(2):308-316. doi: 10.1038/s41431-018-0279-z. Epub 2018 Oct 24.

17.

Symptoms and feelings valued by patients after a percutaneous coronary intervention: a discrete-choice experiment to inform development of a new patient-reported outcome.

Barker AL, Peeters G, Morello RT, Norman R, Ayton D, Lefkovits J, Brennan A, Evans SM, Zalcberg J, Reid C, Ahern S, Soh SE, Stoelwinder J, McNeil JJ.

BMJ Open. 2018 Oct 18;8(10):e023141. doi: 10.1136/bmjopen-2018-023141.

18.

Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study.

Ho CLB, Chowdhury EK, Breslin M, Doust J, Reid CM, Wing LMH, Nelson MR; 2nd Australian National Blood Pressure Study Management Committee.

J Clin Lipidol. 2019 Jan - Feb;13(1):148-155. doi: 10.1016/j.jacl.2018.08.014. Epub 2018 Sep 6.

PMID:
30293937
19.

Monitoring outcomes in spine surgery: rationale behind the Australian Spine Registry.

Ahern S, Apos E, McNeil JJ, Cunningham J, Johnson M.

ANZ J Surg. 2018 Oct;88(10):950-951. doi: 10.1111/ans.14562. No abstract available.

PMID:
30276998
20.

Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.

Woodcock F, Doble B; CANCER 2015 Consortium.

Med Decis Making. 2018 Nov;38(8):954-967. doi: 10.1177/0272989X18797588. Epub 2018 Sep 18.

PMID:
30226101

Supplemental Content

Loading ...
Support Center